Abstract Memory programming of cytotoxic T cells (CTLs) by inflammatory cytokines can be regulated by mammalian target of rapamycin (mTOR). We have shown that inhibition of mTOR during CTL activation leads to the enhancement of memory, but the molecular mechanisms remain largely unknown. Using high-throughput RNA-Seq, we identified genes and functions in mouse CTLs affected by mTOR inhibition through rapamycin. Of the 43,221 identified transcripts, 184 transcripts were differentially expressed after rapamycin treatment, corresponding to 128 annotated genes. Of these genes, 114 were downregulated and only 14 were upregulated. Most importantly, 50 of them are directly related to cell death and survival. In addition, several genes such as CD62L are related to migration. Furthermore, we predicted downregulation of transcriptional regulators based on the total differentially expressed genes, as well as the subset of apoptosis-related genes. Quantitative PCR confirmed the differential expressions detected in RNA-Seq. We conclude that the regulatory function of rapamycin may work through inhibition of multiple genes related to apoptosis and migration, which enhance CTL survival into memory.
Introduction
Generation of functional memory cytotoxic T cells (CTLs) holds promise for vaccines against some important chronic infections. However, effective strategies have not yet become available (Mescher et al. 2006) . Activation of naive CTLs requires three signals: the antigen derived from the proliferating pathogen, a costimulation provided by dendritic cells, and a third signal provided by inflammatory cytokines (Curtsinger et al. 2003; Mescher et al. 2006) . Deficiency of signaling to IL-12 and interferon (IFN)-α abolishes memory CTL formation during infections, further supporting the critical role of inflammatory cytokines in memory CTL generation (Xiao et al. 2009 ). In addition, IL-12 can program memory CTLs in in vitro activation (Rao et al. 2010; Xiao et al. 2009 ), suggesting that programming of memory CTLs may take place during early activation, as demonstrated in some infections (Badovinac et al. 2004) .
mTOR is a critical regulator of cells' response to environmental factors, such as energy levels, insulin, and other growth factors (Thomson et al. 2009 ). Recently, inhibition of mTOR in mice was reported to enhance memory CTL generation during infections through suppressing mTORC1 or modulating cell metabolisms (Araki et al. 2009; Pearce et al. 2009 ). Inhibition of mTOR using rapamycin during CTL activation leads to increased memory programming Rao et al. 2010) , which is related to increased memory CTL precursors and their survival (Rao et al. 2010) , and increased expansion . However, how rapamycin regulates this memory CTL programming has not been evaluated on a global level.
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RNA-Seq is a recently developed approach using highthroughput sequencing technologies. It allows global characterization and quantification of transcriptomes, which provide a precise measurement of transcripts (Ozsolak and Milos 2011) . RNA-Seq has generated exciting results in the study of cancers and immune-related diseases (Ceol et al. 2011) . To determine the regulatory mechanisms of rapamycin on memory CTLs, we examined the differential gene expression in CTLs with rapamycin treatment using high-throughput RNASeq. Among 43,221 transcripts, 183 transcripts were found to be differentially expressed in rapamycin treatment as compared to the control, corresponding to 128 annotated genes in Ensembl database. Of these genes, many were directly implicated in immune function and cell survival. Most of the differentially expressed genes were downregulated, including genes associated with cell death and survival. The predicted transcriptional regulators were inhibited by rapamycin based on the total differentially expressed genes, as well as genes related to apoptosis and migration. Therefore, we consider that rapamycin may enhance memory CTL programming through promoting survival and regulating migration.
Materials and methods

Animal
OT-I mice, gifts from MF Mescher, University of Minnesota, MN, express a transgenic TCR specific for H-2Kb OVA257-26. The mice were housed in specific pathogen-free conditions at the University of Maryland. These studies have been reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of the University of Maryland (protocol ID R-12-23). All conjugated fluorescent Abs were purchased from BD Biosciences (San Diego, CA), eBioscience (San Diego, CA), or Biolegend (San Diego, CA).
T cell purification
This was performed in the same way we reported previously [16] . In brief, inguinal, axillary, brachial, cervical, and mesenteric lymph nodes (LNs) were harvested from WT OT-I mice. The nodes were then pooled and disrupted to obtain a single cell suspension necessary for CD8+ CD44lo cell enrichment. The enrichment was performed using negative selection with MACS magnetic beads (Miltenyi Biotec). This involved coating the cells with fluorescein isothiocyanate (FITC)-labeled antibodies specific for CD4, B220, I-Ab, and CD44. Anti-FITC magnetic MicroBeads (Miltenyi Biotech) were then added, and the suspension passed through separation columns attached to a MACS magnet. Cells that did not bind were collected and were >95 % CD8+ and <0.5 % CD44hi.
In vitro stimulation of naive OT-I T cells Naive OT-I CD8 cells were purified as described above and stimulated for 3 days in vitro in flat-bottom microtiter wells stimulated with antigen (DimerX H-2Kb:Ig fusion protein loaded with OVA 257-264 peptide; BD Pharmingen), recombinant B7-1/Fc chimeric protein (R&D Systems), and 2 U/ml of murine rIL-12 (R&D Systems) as previously described Xiao et al. 2009 ). Cells ( 3×10 5 ) in 1.5-ml Allos media were placed in each well, and 2.5 U/ml IL-2 was added to all wells (24-well plate). For rapamycin-treated CTLs, cultures were supplemented with rapamycin at 250 ng/ml. Rapamycin was purchased from EMD (Gibbstown, NJ).
RNA preparation RNA samples were extracted using RNeasy Micro kit (Qiagen) following the manufacturer's instruction. The isolated RNA samples were stored at −80°C upon to use.
RNA-Seq construct preparation cDNA libraries were prepared from 1 μg of RNA per sample using Illumina TruSeq RNA Sample Preparation v2 kit following the manufacturer's instructions. Sequencing libraries were created and sequenced with Illumina's HiSeq 1000 at the University of Maryland IBBR Sequencing facility. In brief, samples were tested for quality with the Agilent Bioanalyzer chip before Illumina adapters were added after PCR amplification. Fifteen cycles of PCR were used to amplify the cDNA library with Illumina adaptors. qPCR was also performed for quantity check after the Illumina cDNA libraries were prepared. Finally, cluster generation was performed using Illumina cBot at 15 pM starting concentration for each library. The libraries were barcoded, multiplexed, and sequenced in one HiSeq 1000 lane on the Illumina's HiSeq 1000.
Pre-process and analyzing RNA-Seq reads using TopHat-Cufflinks
The raw quality of the reads of rapamycin-treated and control samples was checked using FastQC (http://www. bioinformatics.babraham.ac.uk/projects/fastqc/). Based on the FastQC summarized statistics, we trimmed and the first 13 bp of low-quality reads using fastx_trimmer in the Fastx toolkit (http://hannonlab.cshl.edu/fastx_toolkit/index.html). The final reads were mapped to the reference mouse genome (mm9, NCBI Build 37) using TopHat (v-2.0.4.Linux_x86_ 64) (Kim et al. 2013) . Cufflinks (v-2.0.2) was employed to assemble transcript models from RNA-Seq alignments and to estimate transcript and abundances (Trapnell et al. 2010 ). Differential expression of annotated genes was identified using Cuffdiff ), a program in the Cufflinks, and the upper quartile normalization option was used to improve differential expression tests for less abundant transcripts. Genes with a false discovery rate (FDR) <0.05 were considered significant. Otherwise, the default options were used in these software packages in our analyses (Trapnell et al. 2012 ).
Enriched pathway analysis of differentially expressed genes
To further identify canonical signaling pathways, molecular networks, and biological functions, 128 genes determined to be significantly differentially expressed between rapamycin treatment and control by TopHat/Cufflinks were uploaded into the Ingenuity Pathways Analysis (IPA) software (Ingenuity Systems, http://www.ingenuity.com). The IPA database is maintained and edited by humans and contains genes, proteins, and RNA in order to not only find associations between expression data and canonical pathways, but also build new networks. The significance of associations was computed using the right-tailed Fisher exact test. All signaling pathways identified by IPA with a P value ≤0.05 have a statistically significant, nonrandom association.
Real-time RT-PCR cDNA was synthesized from purified RNA using QuantiTech Reverse Transcription kit (Qiagen). The synthesized cDNAs were further 1:20 diluted with Rnase-and Dnase-free water. Quantitation PCR was performed using 2 μl of diluted cDNA as a template in a 20 μl of SYBR Green (Bio-Rad) supermix reaction on a MyiQ™ Single-Color Real-Time PCR Detection System (Bio-Rad). Details of the real-time PCR conditions used are available upon request. Primer sequences are listed in Table S4 .
Results
RNA-Seq analysis of CTLs
We have shown that IL-12 can program memory CTLs during in vitro activation (Xiao et al. 2009 ). This memory programming can be further enhanced by inhibition of mTOR by rapamycin ( Fig. 1) . Rapamycin can increase the memory formation ( Fig. 1a) and promote a more central memory phenotype (CD62L hi/KLRG1 lo) (Fig. 1b) , consistent with recent reports Rao et al. 2010) . To further study the underlying molecular mechanisms of rapamycin in this regulation, naive OT-I cells were purified and subsequently stimulated by three signals (antigen, costimulation, and interleukin-12) in the presence or absence of rapamycin, as described previously . Stimulated cells were harvested 3 days after in vitro stimulation, and RNA was purified from these samples. After construction of complementary DNA (cDNA) libraries, whole transcriptome RNASeq was performed to determine the differences in gene expression between rapamycin-treated and control CTLs, as demonstrated in Fig. S1 . Sequence statistics were analyzed with FastQC (http://www.bioinformatics.bbsrc.ac.uk/projects/ fastqcwebsite). Base sequence qualities and proportion of bases per cycle are shown in Fig. S2 .
Based on the initial FastQC report, we trimmed the first 13 bp from all reads due to their low quality. Analysis of the trimmed reads was done using TopHat software for alignment with the reference genome (NCBI37/mm9.0). Of the total sequenced fragments, 91.20 and 90.98 %were mapped to the reference genome, respectively (Table S1 ). In addition, the number of reads was comparable between rapamycin treated and control (Fig. S3) . The high-quality reads were then used for the downstream TopHat-Cufflinks pipeline analysis.
Identification of differentially expressed genes
The application of RNA-Seq to immunology facilitates the global analysis of gene differential expression in response to rapamycin treatment in CTLs. Overall, we tested a total of 43,221 transcripts. Of these, 184 were determined by Cuffdiff method to be significantly differentially expressed after Benjamini-Hochberg correction for multiple testing (Fig. 2) corresponding to 128 genes (false discovery rate (FDR) <0.05). As seen in Fig. 3 , of these 128 differentially expressed genes, 14 genes were upregulated by rapamycin and 114 were found to be downregulated (Table S2) .
To investigate the molecular and cellular functions modulated by rapamycin, the significantly differentially expressed genes were submitted to Ingenuity Pathway Analysis (IPA) version 16542223 (Ingenuity Systems, Inc., Redwood City, CA). The first function affected by rapamycin was cell death and survival, which involves 50 genes, followed by cellular function and maintenance (42 genes), small molecule biochemistry (39 genes), cellular movement (35 genes), and cell-to-cell signaling and interaction (37 genes) ( Table 1 ). This suggests that regulation of cell death and survival may be an important function of rapamycin during memory programming. To further investigate the functions, differentially expressed genes were separated as downregulated (114) and upregulated (14) and imported into IPA as individual group. Cell death and survival and cellular function and maintenance were the top functions in the downregulated genes, whereas cellular movement was the top function in upregulated genes (Table 2) . Therefore, rapamycin may suppress apoptosis of CTLs by affecting multiple genes.
Apoptosis is one of the major mechanisms for CTL contraction, during which about 90 to 95 % of effector CTLs disappear, and the remaining small fraction becomes memory cells (Kaech et al. 2002; Wherry et al. 2003) . Several of these genes are involved in apoptosis in CTLs, such as perforin and granzyme (Badovinac et al. 2004; Mescher et al. 2006 ), but most of them have not been directly studied in CTLs (Tables 3  and S3 ). Rapamycin generally regulated apoptotic genes through inhibition of genes that promote apoptosis. For example, cyclin-dependent kinase inhibitor 1A (CDKN1A) is involved in the gene suppression by tumor protein p53 (TP53), so inhibition of CDKN1A by rapamycin will reduce the suppression of P53-responsive genes like survivin (Lohr et al. 2003) . Transforming growth factor beta 3 (TGFB3) is involved in the apoptosis of cells in intestinal mucosa (Dunker et al. 2002) , and TGFB3 may be required in FasL-FasCaspase pathway (Huang et al. 2011) . TIMP metallopeptidase inhibitor 3 (TRIMP-3) promotes apoptosis in lung carcinoma (Kallio et al. 2011) . Both TGFB3 and TIMP3 were inhibited by rapamycin, which should enhance CTL survival. On the other hand, the genes promoting survival were upregulated. For instance, colony-stimulating factor 1 (CSF-1) decreases apoptosis (Menke et al. 2009 ), and its expression was increased by rapamycin. Therefore, rapamycin may enhance the memory CTL programming by suppressing apoptosis and enhancing survival.
There were 14 genes upregulated by rapamycin (Table S2) , including CD62L (Araki et al. 2011; Li et al. 2011) , which is an important marker for central memory CTL and directs the migration of immune cells to secondary lymphoid tissues (Obar and Lefrancois 2010) . Another adhesion molecule, CXCL10, was also enhanced by rapamycin. CXCL10 (another name IP-10) is a chemokine mainly produced by macrophages and dendritic cells during infections (Liu et al. 2011 ) and can also be produced by mucosal CD4 and NK cells (Singh et al. 2008 ). This chemokine is critical for recruitment of immune cells, including CTLs, to the site of infection to perform immune function (Liu et al. 2011) . Therefore, the regulation of rapamycin on CTLs may include two aspects: to enhance their survival, thus forming more memory, and also to take an active route to circulating both inside secondary lymphoid tissues and original site of infection.
IPA predicted that the cytotoxicity of the cells in the rapamycin-treated group was overall decreased as compared to control (Fig. S4 ). This determination was based on the downregulation of genes such as granzyme and perforin, which are the key cytotoxic proteins used by CTLs to kill their targets (Curtsinger et al. 2003; Mescher et al. 2006) . A serine protease inhibitor Spi2a (Serpina3g), which has been implicated in aiding memory CTL formation (Liu et al. 2004 ), was upregulated. This means that rapamycin may also regulate memory-related genes like Spi2a directly. The decrease in these cytotoxic genes, along with the increase in expression of Serpina3g, may also be one of the mechanisms contributing to greater memory formation. Network analysis of apoptosis-related genes regulated by rapamycin There were 45 apoptosis-related genes regulated by rapamycin (Table 3 and Table S3 ). By running through IPA program, 27 of them were directly connected in a network (Fig. 4) . This suggests that there may be common upstream molecules responsible for their regulation. The analysis of upstream Fig. 3 Significantly differentially expressed genes identified by Cuffdiff with differential fold change molecules identified some important transcriptional regulators linked to these 45 apoptosis-related genes (Fig. S5 ). STAT4 is a critical transcription factor involved in IL-12 signaling (Watford et al. 2004) , and the genes regulated by rapamycin suggested that STAT4 function was inhibited. In addition, tumor protein p63 (TP63) shares high structure similarity with TP53 and interacts with TP53 and tumor protein p73 (TP73) in tumorigenesis (Graziano and De Laurenzi 2011) . TP63 induces apoptosis in addition to its critical role in development and epithelial differentiation (Dotsch et al. 2010) ; therefore, the inhibition of TP63 may suppress apoptosis, thus enhancing CTL survival to become memory. Interestingly, three upstream transcription regulators regulated by rapamycin were related to hypoxic conditions: aryl hydrocarbon receptor nuclear translocator 2 (ARNT2) (Garritano et al. 2013) , hypoxiainducible factor 1-alpha (HIF-1) (Barbi et al. 2013) , and single-minded homolog 1 (SIM1) (Michaud et al. 1998) . This suggests that rapamycin may induce a hypoxia-like response in CTLs. Interestingly, HIF-1 is required for Th17 generation (Barbi et al. 2013 ).
Quantitative RT-PCR validation of the RNA-Seq results
To validate the precision of our RNA-Seq data, we randomly selected 15 candidate genes (10 downregulated, 5 upregulated) to perform real-time reverse transcription (RT)-PCR. These genes cover immune function, migration, and apoptosis. Realtime PCR found that the expression levels were consistent with the results detected in RNA-Seq and all ten downregulated genes were downregulated in real-time PCR, whereas upregulated genes were also enhanced by rapamycin in real-time PCR (Fig. 5a) . To compare the expression levels directly in both RNA-Seq and real-time PCR, we performed Spearman rank correlation. These two data sets were nicely correlated ( Fig. 5b) , with Pearson correlation value rho=0.9285714, and P value<2.2E−16. All the PCR products were confirmed by sequencing. Thus, RNA-Seq gave reliable gene expression measurements, which were validated by quantitative PCR.
Discussion
Rapamycin enhances memory CTL programming Rao et al. 2010 ), which could be related to mTORC1 (Zeng et al. 2013) . Using high-throughput sequencing, we were able to find only 128 genes that were significantly altered by rapamycin, and most of them were inhibited, which is consistent with the function of mTOR in cell growth and proliferation (Araki et al. 2009; Chi 2012; Hara et al. 2002) . Of them, 45 genes are directly related to apoptosis (Table 3) , and most of these genes are somewhat connected (Fig. 4) . This suggests that effects of the regulation of mTOR by rapamycin on memory CTL programming may be related to regulation of survival for activated CTLs. Survival signals for CTLs can be provided by stimulation from T cell receptor (TCR), costimulation and cytokines Williams and Bevan 2007) , presumably through regulation of prosurvival and proapoptotic molecules, such as Bcl-2 and Bim in Bcl-2 family (Gillings et al. 2009 ). Many transcription factors are known to be involved in Bcl-2 regulation including cyclic AMP response element-binding (CREB) protein (Xiang et al. 2006 ) and STAT5 (Hand et al. 2010) . In addition, transcription factors traditionally belonging to other pathways participate in the regulation of cell survival. T cell factor 1 in canonical Wnt signaling (Staal et al. 2008 ) modulates memory CTLs through regulation of Bcl-2 expression and IL-2/IL-15 signaling (Zhou et al. 2010) . Similarly, proapoptotic molecules can also be regulated by transcription factors. Forkhead box O transcription factor 1 (FOXO1) regulates expression of Fas and Bim (Dejean et al. 2010; Kerdiles et al. 2009 ). Because survival is a key for memory CTLs, it is possible that the regulation of critical transcription factors is one of the major molecular mechanisms for rapamycin's regulation on memory programming. We found that most of genes related to apoptosis were inhibited by rapamycin. Although further functional study is warranted, we postulate that this apoptosis regulation by rapamycin may be not single gene dependent, but rather a general feature of regulation of multiple genes. Treatment with rapamycin modifies the effects of IL-12 on 3SI CD8 T cells. The addition of rapamycin decreased genes related to effector killing functions such as granzyme and perforin, as opposed to 3SI (antigen, costimulation plus IL-12) treatment without rapamycin which upregulated those genes compared to 2SI (only antigen and costimulation). Agarwal et al. found that CD62L (SELL) was downregulated in the 3SI-treated CD8 T cells compared to 2SI (Agarwal et al. 2009 ) but was upregulated in the 3SI + rapamycin treatment (Fig. 5) . Some apoptosis-related genes were also upregulated in 3SI treatment versus 2SI (Agarwal et al. 2009 ) but were downregulated in the rapamycin-treated 3SI cells (Table 3 and  S3) . These include PERP, TRIB3, CDKN1A, EIF4EBP1, and DDIT4, and TGF-β-related genes. TGFB3 was downregulated by rapamycin, while 3SI upregulated TGFB3 compared to 2SI (Agarwal et al. 2009 ). Furthermore, ACVRL1, a type I cell-surface receptor for TGF-β, was upregulated by IL-12, but downregulated by 3SI + rapamycin treatment. Therefore, rapamycin may enhance memory CTL programming by modulating some of the effects of IL-12.
CXCL10 is critical for the induction of protective CTLs in intracellular parasite infections (Majumder et al. 2012) . CXCL10 is induced by IFN-γ/TNF-α/IL-1 (Liu et al. 2011) and recently is reported to be induced by type I IFN-α during LCMV infection (Sung et al. 2012) . The receptor for CXCL10 is CXCR3, which also binds to CXCL9 and CXCL11 (Singh et al. 2008 ). Agarwal et al. reported that CXCL10 is upregulated in CTLs by IFN-α, but not IL-12 during in vitro stimulation (Agarwal et al. 2009 ). This gene was drastically upregulated by rapamycin (Fig. 5) . Interestingly, CXCR3, the receptor for CXCL10 was also enhanced by rapamycin (data not shown) and is regulated by IL-12 (Agarwal et al. 2009 ). This means that rapamycin is regulating the expression of a pair of adhesion molecules, CXCL10 and CXCR3. It is possible that this paired regulation enables activated CTLs to migrate to the site of infection more efficiently as a group. Further experiments are needed to determine if this is functionally significant.
The upregulation of CXCL10 and CD62L by rapamycin suggests that the memory programming is not only regulating survival, but also directing the CTLs where to migrate, which is consistent with previous reports Rao et al. 2010) . The central memory phenotype of the rapamycinregulated memory CTLs may keep most of them in circulating the secondary lymphoid tissues (Obar and Lefrancois 2010) , whereas the effector memory CTLs reside in the tissues (Jameson and Masopust 2009 ). This T CM resides close to the entry channel in draining lymph nodes, which makes them accessible to the draining pathogen through the tunnel (Kastenmuller et al. 2013; Sung et al. 2012 ). The residence of T CM may be directed by different chemokines in different infections (Kastenmuller et al. 2013; Sung et al. 2012 ). Therefore, we postulate that the regulatory function of rapamycin on memory programming is through an integrated process: regulation of apoptosis and cell migration as a general pattern of biological process.
